← Back to Search

Orthopedic Implant

Cable plating with strut for Femur Fractures

N/A
Waitlist Available
Led By Emil Schemitsch, MD, FRCS(C)
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will compare two different treatments for fixing a Vancouver B1 periprosthetic to see which one leads to a faster return to function.

Eligible Conditions
  • Femur Fracture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
TUG test score at 6 weeks post-op
Secondary outcome measures
Re-operation rates

Trial Design

2Treatment groups
Active Control
Group I: Cable plating with strutActive Control1 Intervention
The plate will be placed laterally with the allograft strut placed on the anterior cortex. Screw fixation will be used distal to the stem and cables and screws will be used proximal to the stem tip. Cerclage cables or wires will be used to secure the strut.
Group II: isolated platingActive Control1 Intervention
A lateral thigh incision will be used to expose the fracture site. Surgeons will attempt to minimize devascularization of the bone by meticulous dissection and indirect reduction techniques. An appropriate sized plate will be applied to the lateral aspect of the femur. Fracture reduction will be achieved with the use of intra-operative fluoroscopy and the plate will be secured with locking screws.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
545 Previous Clinical Trials
450,383 Total Patients Enrolled
Emil Schemitsch, MD, FRCS(C)Principal InvestigatorUnity Health Toronto
Aaron Nauth, MD, FRCSCPrincipal InvestigatorUnity Health Toronto
2 Previous Clinical Trials
361 Total Patients Enrolled
~7 spots leftby May 2025